Sign Up to like & get
recommendations!
0
Published in 2020 at "EJNMMI Research"
DOI: 10.1186/s13550-020-00654-w
Abstract: Background Preclinical and clinical studies have demonstrated that immunotherapy has effectively delayed tumor progression, and the clinical outcomes of anti-PD-1/PD-L1 therapy were related to PD-L1 expression level in the tumors. A 131 I-labeled anti-PD-L1 monoclonal…
read more here.
Keywords:
cerenkov luminescence;
131 mab;
colorectal cancer;
luminescence imaging ... See more keywords